Oragenics, Inc.
Oragenics, Inc. (OGEN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · OGEN · as of Sep 30, 2025
Ownership Breakdown
15
Institutional Holders
▼ 3 vs Q2
$160,519
Total Inst. Value
▼ $241,054 vs Q2
4.51M
Shares Outstanding
freeFloat 97.71%
122,534
13F Shares Held
▲ 17,261 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
OGEN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
DRW SECURITIES, LLC pharmaceutical preparations | 61.8K | 1.45% | 1.45% | $80.97M | Nov 14, 2025 | NEW |
SABBY MANAGEMENT, LLC pharmaceutical preparations | 59.0K | 1.38% | 1.38% | $77.23M | Nov 14, 2025 | NEW |
BLACKROCK, INC. pharmaceutical preparations | 703 | 1.65% | 1.65% | $921,000 | Nov 12, 2025 | ▲ 2 |
ALLWORTH FINANCIAL LP pharmaceutical preparations | 334 | 0.78% | 0.78% | $438,000 | Dec 2, 2025 | NEW |
UBS GROUP AG pharmaceutical preparations | 271 | 0.63% | 0.63% | $355,000 | Nov 13, 2025 | ▼ 1.6K |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 208 | 0.49% | 0.49% | $272,000 | Nov 14, 2025 | ▼ 457 |
MORGAN STANLEY pharmaceutical preparations | 138 | 0.32% | 0.32% | $181,000 | May 27, 2026 | ▼ 11.8K |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 36 | 0.08% | 0.08% | $47,000 | Feb 3, 2026 | ▼ 15.5K |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 34 | 0.08% | 0.08% | $45,000 | Nov 13, 2025 | — held |
HARBOUR INVESTMENTS, INC. pharmaceutical preparations | 34 | 0.08% | 0.08% | $45,000 | Nov 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
1
Increased
+2 shares4
New Positions
first time holders4
Decreased
−29.4K shares6
Sold Out
fully exitedNet shares change (top 50)
29.4K
+2 / −29.4K
Net new holders
-5
4 new / 6 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
OGEN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Telling Fred director | Dec 12, 2025 | Sale | 210 | $0.94 | $198.366 | 948 | Form 4 ↗ |
Huffman Janet CEO and CFO | Dec 11, 2025 | Award | 250,000 | $0.93 | $232.5K | 250.0K | Form 4 ↗ |
Giordano Natasha director | Dec 11, 2025 | Award | 125,000 | $0.93 | $116.3K | 125.0K | Form 4 ↗ |
Giordano Natasha director | Dec 11, 2025 | Award | 38,320 | $1.03 | $39.5K | 38.3K | Form 4 ↗ |
Telling Fred director | Dec 11, 2025 | Award | 125,000 | $0.93 | $116.3K | 125.0K | Form 4 ↗ |
Telling Fred director | Dec 12, 2025 | Sale | 210 | $0.94 | $198.366 | 34.5K | Form 4 ↗ |
GANDOLFO JOHN P director | Dec 11, 2025 | Award | 125,000 | $0.93 | $116.3K | 125.0K | Form 4 ↗ |
DUNTON ALAN W director | Dec 11, 2025 | Award | 125,000 | $0.93 | $116.3K | 125.0K | Form 4 ↗ |
KOSKI ROBERT C director | Dec 11, 2025 | Award | 125,000 | $0.93 | $116.3K | 125.0K | Form 4 ↗ |
POPE CHARLES L director | Dec 11, 2025 | Award | 125,000 | $0.93 | $116.3K | 125.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Oragenics, Inc. (OGEN) is primarily owned by institutional investors, who hold approximately 2.7% of total shares outstanding. Company insiders own approximately 2.29%, while retail and public investors account for the remaining 94.99%.
The largest institutional shareholder of Oragenics, Inc. is DRW SECURITIES, LLC, holding approximately 61,809 shares — equal to 1.45% of outstanding shares — as of September 30, 2025.
A total of 15 institutional investors currently hold OGEN stock, with a combined institutional value of approximately $160,519 as of the most recent 13F filing period.
Frequently asked questions
OGEN ownershipOragenics, Inc. (OGEN) is primarily owned by institutional investors, who hold approximately 2.7% of shares. The largest shareholder is DRW SECURITIES, LLC with a 1.45% stake. Company insiders hold 2.29%. Data sourced from SEC Form 13F as of September 30, 2025.